1. Home
  2. TNGX vs TATT Comparison

TNGX vs TATT Comparison

Compare TNGX & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • TATT
  • Stock Information
  • Founded
  • TNGX 2014
  • TATT 1985
  • Country
  • TNGX United States
  • TATT Israel
  • Employees
  • TNGX N/A
  • TATT N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • TATT Aerospace
  • Sector
  • TNGX Health Care
  • TATT Industrials
  • Exchange
  • TNGX Nasdaq
  • TATT Nasdaq
  • Market Cap
  • TNGX 317.4M
  • TATT 309.5M
  • IPO Year
  • TNGX N/A
  • TATT 1987
  • Fundamental
  • Price
  • TNGX $3.35
  • TATT $30.42
  • Analyst Decision
  • TNGX Strong Buy
  • TATT
  • Analyst Count
  • TNGX 8
  • TATT 0
  • Target Price
  • TNGX $13.14
  • TATT N/A
  • AVG Volume (30 Days)
  • TNGX 757.1K
  • TATT 69.6K
  • Earning Date
  • TNGX 03-17-2025
  • TATT 03-05-2025
  • Dividend Yield
  • TNGX N/A
  • TATT N/A
  • EPS Growth
  • TNGX N/A
  • TATT 43.74
  • EPS
  • TNGX N/A
  • TATT 0.76
  • Revenue
  • TNGX $43,383,000.00
  • TATT $142,909,000.00
  • Revenue This Year
  • TNGX $27.73
  • TATT $33.56
  • Revenue Next Year
  • TNGX N/A
  • TATT $14.09
  • P/E Ratio
  • TNGX N/A
  • TATT $39.83
  • Revenue Growth
  • TNGX 15.67
  • TATT 36.36
  • 52 Week Low
  • TNGX $2.59
  • TATT $10.51
  • 52 Week High
  • TNGX $12.89
  • TATT $33.37
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 58.01
  • TATT 56.93
  • Support Level
  • TNGX $2.82
  • TATT $28.10
  • Resistance Level
  • TNGX $3.20
  • TATT $32.94
  • Average True Range (ATR)
  • TNGX 0.20
  • TATT 1.89
  • MACD
  • TNGX 0.05
  • TATT -0.09
  • Stochastic Oscillator
  • TNGX 97.40
  • TATT 49.92

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd is a provider of solutions and services to the aerospace and defence industries focused mainly on the four segments: Original equipment manufacturing (OEM); MRO services for heat transfer; MRO services for aviation components; Overhaul and coating of jet engine components. The company designs, develops, and manufactures Heat Exchangers, Cooling Systems, Cold Plates, Vapor-Cycle Air Conditioning Systems (for both land and airborne applications), and flow accessories.

Share on Social Networks: